Pulsenmore’s Partnership with Ouma Health Aims to Transform Remote Prenatal Care Nationwide
Market Chameleon (Wed, 24-Jun 6:29 AM ET)
Why Is Penny Stock Pulsenmore (PLSM) Up Today?
TipRanks (Wed, 24-Jun 9:09 AM ET)
PLSM Partners with Ouma Health to Bridge the Gap in Prenatal Care with Home Ultrasound Technology
Market Chameleon (Wed, 24-Jun 3:48 AM ET)
PRNewswire (Wed, 24-Jun 7:00 AM ET)
Pulsenmore Announces Full Year 2025 Financial Results and Webcast
PRNewswire (Mon, 30-Mar 8:29 AM ET)
Pulsenmore Announces Full Year 2025 Earnings Conference Call
PRNewswire (Wed, 25-Mar 8:00 AM ET)
Pulsenmore Ltd is an emerging medical device company engaged in the research, development, manufacturing, marketing, and sale of non-invasive portable ultrasound solutions for home use. Its products include the Pulsenmore ES and Pulsenmore FC, along with the early-stage Pulsenmore MC, collectively referred to as Pulsenmore Products, enabling remote ultrasound scans in gynecology and other fields such as pulmonary, cardiology, and urology through telemedicine. The Company operates in a single segment focused on developing and commercializing portable ultrasound technologies, with Israel contributing the majority of its revenue.
Pulsenmore Ltd. - trades on the NASDAQ stock market under the symbol PLSM.
As of June 24, 2026, PLSM stock price climbed to $6.59 with 34,657,778 million shares trading.
PLSM has a beta of 1.46, meaning it tends to be more sensitive to market movements. PLSM has a correlation of 0.10 to the broad based SPY ETF.
PLSM has a market cap of $42.85 million. This is considered a Sub-Micro Cap stock.
PLSM support price is $3.11 and resistance is $3.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PLSM shares will trade within this expected range on the day.